We are live on
!
Find out more
PMSA
Patrick M. Sweeney & Associates Portfolio holdings
AUM
$156M
1-Year Est. Return
19.16%
This Fund
S&P 500
This Quarter
Est. Return
-0.63%
1 Year Est. Return
+19.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$156M
AUM Growth
-$3.89M
(-2.4%)
Cap. Flow
+$584K
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
35.72%
Holding
166
New
7
Increased
70
Reduced
42
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$483K |
| 2 |
Aon
AON
|
+$470K |
| 3 |
Dow Inc
DOW
|
+$232K |
| 4 |
iShares Gold Trust
IAU
|
+$217K |
| 5 |
EOG Resources
EOG
|
+$206K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$481K |
| 2 |
NVIDIA
NVDA
|
+$437K |
| 3 |
Constellation Energy
CEG
|
+$248K |
| 4 |
Walmart Inc
WMT
|
+$63.7K |
| 5 |
Apple
AAPL
|
+$53.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.4% |
| 2 | Financials | 18.29% |
| 3 | Industrials | 15.67% |
| 4 | Technology | 13.6% |
| 5 | Consumer Staples | 4.99% |
Similar funds
BCM
IWA
CFG
BCM
AIS
BWM
MCA
TI
Patrick M. Sweeney & Associates's Q1 2026 Portfolio in Review
As of Q1 2026, Patrick M. Sweeney & Associates held 166 positions worth $156M, down 2.4% from $160M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Patrick M. Sweeney & Associates's Q1 2026 filing shows 7 new, 70 increased, 42 reduced and 2 closed positions. Its largest new stake was Bristol-Myers Squibb: 8,286 shares worth $503K. The largest sale was Novo Nordisk, an estimated $481K.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Financials and Industrials.
- Patrick M. Sweeney & Associates's largest Q1 2026 buy was Bristol-Myers Squibb: 8,286 shares worth $503K.
- Patrick M. Sweeney & Associates added most to Tesla in Q1 2026, an estimated $49.8K increase.
- Patrick M. Sweeney & Associates's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $437K.
- Patrick M. Sweeney & Associates fully exited Novo Nordisk in Q1 2026, selling an estimated $481K.
- Patrick M. Sweeney & Associates's ten largest holdings make up 36% of its $156M portfolio in Q1 2026.
- Patrick M. Sweeney & Associates opened 7 new positions and closed 2 in Q1 2026.
- Patrick M. Sweeney & Associates's portfolio value fell 2.4% quarter-over-quarter to $156M.
Based on Patrick M. Sweeney & Associates's 13F filing for Q1 2026, filed 7 May 2026.